We assessed the clinical utility of [ 11 C]flumazenil-PET (FMZ-PET) prospectively in 100 epileptic patients undergoing a pre-surgical evaluation, and defined the specific contribution of this neuro-imaging technique with respect to those of MRI and [ 18 F]fluorodeoxyglucose-PET (FDG-PET). All patients benefited from a long term video-EEG monitoring, whereas an intracranial EEG investigation was performed in 40 cases. Most of our patients (73%) demonstrated a FMZ-PET abnormality; this hit rate was significantly higher in temporal lobe epilepsy (94%) than in other types of epilepsy (50%) (P < 0.001). Most FMZ-PET findings coexisted with a MRI abnormality (81%), including hippocampal atrophy (35%) and focal hypometabolism on FDG-PET (89%). The area of decreased FMZ binding was often smaller than that of glucose hypometabolism (48%) or larger than that of the MRI abnormality (28%). FMZ-PET did not prove superior to FDG-PET in assessing the extent
Introduction
Cerebral benzodiazepine (BZD) receptors have been studied in epileptic patients for almost a decade, using [ 11 C]flumazenil-PET (FMZ-PET) (Savic et al., 1988) . Most attention has been directed toward focal abnormalities in drug-resistant partial epilepsies, with the hope of better delineation of the epileptogenic zone, non-invasively (Savic et al., 1988 (Savic et al., , 1993 Henry et al., 1993; Szelies et al., 1996; Debets et al., 1997) . In fact, almost all reported patients with refractory partial seizures demonstrated a localized reduction of FMZ binding, which correlated closely with the side and site of seizure onset (Savic et al., 1988 (Savic et al., , 1993 (Savic et al., , 1995 Henry © Oxford University Press 1998 of the ictal onset zone, as defined by intracranial EEG recordings. However, it provided useful data which were complementary to those of MRI and FDG-PET in three situations: (i) in temporal lobe epilepsy associated with MRI signs of hippocampal sclerosis, FMZ-PET abnormalities delineated the site of seizure onset precisely, whenever they were coextensive with FDG-PET abnormalities; (ii) in bi-temporal epilepsy, FMZ-PET helped to confirm the bilateral origin of seizures by showing a specific pattern of decreased FMZ binding in both temporal lobes in 33% of cases; (iii) in patients with a unilateral cryptogenic frontal lobe epilepsy, FMZ-PET provided further evidence of the side and site of seizure onset in 55% of cases. Thus, FMZ-PET deserves to be included in the pre-surgical evaluation of these specific categories of epileptic patients, representing approximately half of the population considered for epilepsy surgery.
et Szelies et al., 1996) . The BZD receptors labelled with [ 11 C]FMZ are modulatory sites of the GABA A receptors, and are primarily expressed on the basal dendrites of a wide variety of neurons. Accordingly, the reduced FMZ binding observed in epileptic patients is thought to largely reflect an underlying neuronal loss, as demonstrated in temporal lobe epilepsy associated with mesial temporal sclerosis (Burdette et al., 1995; Koepp et al., 1996; Debets et al., 1997) . Functional changes of the BZD receptor system also seem to contribute to the abnormalities observed on FMZ-PET images Savic et al., 1996; Koepp et al., 1997) . Despite these promising findings, the clinical utility of FMZ-PET in epilepsy surgery candidates remains poorly defined because of the following limitations. (i) Most published series only included a small number of highly selected temporal lobe epilepsy patients (see Table 1 ), which are not representative of the overall population of patients with refractory partial epilepsy. (ii) MRI was described as normal in most series, even though a majority of the reported temporal lobe epilepsy patients were likely to present with a mesial temporal sclerosis. In fact, MRI signs of mesial temporal sclerosis might well have been overlooked in these patients, inasmuch as no hippocampal volume measurement was performed (Savic et al., 1988 (Savic et al., , 1993 Henry et al., 1993; Szelies et al., 1996) . This issue is of critical importance, since FMZ-PET abnormalities are supposed to mainly reflect mesial temporal sclerosis in temporal lobe epilepsy patients (Debets et al., 1997) . (iii) The extent of the epileptogenic zone was rarely assessed precisely enough to decide whether FMZ-PET or [ 18 F]fluorodeoxyglucose-PET (FDG-PET) findings provided the most pertinent data. Indeed, only 21 patients underwent both PET investigations and an intracranial EEG study (Savic et al., 1993; Debets et al., 1997) . In particular, in temporal lobe epilepsy, the temporal pole, which most often appears hypometabolic on FDG-PET images (Semah et al., 1995) but normal on FMZ-PET images (Koepp et al., , 1997 Debets et al., 1997) , was never specifically evaluated by intracranial EEG recordings. In fact, stereo-EEG (SEEG) recordings often demonstrate that temporolimbic seizures arise concomitantly from the temporal pole and the amygdalohippocampal complex (Ryvlin et al., 1997) .
To evaluate the clinical role of FMZ-PET better, we have investigated 100 consecutive patients prospectively; these were patients referred to our centre for a drug-resistant partial epilepsy, who also benefited from FDG-PET, an optimal MRI study (including hippocampal volume measurements in selected cases) and video-EEG monitoring of their seizures (including an intracranial EEG study in 40 patients). We intended to address the following issues specifically. (i) Does FMZ-PET provide clinically useful data complementary to those obtained with MRI and FDG-PET? If yes, (ii) does this apply to all, or only some, categories of epileptic patients considered for surgery? (iii) Should FDG-PET be replaced by, or combined with, FMZ-PET? (iv) Could FMZ-PET data help to replace intracranial EEG recordings in patients who require this type of investigation at the present time?
Material and methods Subjects
The 100 consecutive epileptic patients with refractory partial epilepsy, included in this study, underwent a FMZ-PET study in our centre between April 1994 and April 1997. All these patients were referred for a presurgical evaluation, and benefited from an optimal MRI, a FDG-PET and a video-EEG monitoring. In addition, 65 underwent a language and memory Wada test (Loring et al., 1990) , and 40 patients intracranial EEG monitoring. Surgery was performed in 44 patients (40% with Ͼ12 months post-surgical follow-up); it was denied in 20 others for various reasons, and planned or still under consideration in the remaining patients. Control subjects included two groups of 12 normal subjects who underwent MRI and either a FDG-PET (n ϭ 12) or a FMZ-PET study (n ϭ 12). Since 1993 the FDG and FMZ-PET studies have been included in the routine presurgical investigations of all patients with refractory partial epilepsy in our department. The use of both PET procedures in normal subjects has been approved by the Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale (CCPRB Lyon) and subjects gave informed consent according to the French legislation
Classification of the epilepsy
Based on all available electro-clinical and MRI data, including well-documented seizures in all cases, the epilepsy was classified as temporal in 52% (46% unilateral and 6% bilateral), frontal in 27%, multilobar in 13% (i.e. temporofrontal in 5%, temporoinsulo-opercular in 4% and temporo-occipital in 4%), parietal in 1%, occipital in 1% and of unknown origin in 6%. This classification can be considered as highly reliable in 83 patients who presented either with one of the following criteria, or with several of them in combination: (i) simple partial seizures with well-localized sensory or motor signs at ictal onset; (ii) a focal MRI abnormality with topographically concordant ictal electroclinical data; (iii) an ictal onset zone mapped by intracranial EEG recordings; and (iv) a temporal lobectomy or lesionectomy based on non-invasive investigations followed by a seizure-free period of ജ1 year postoperatively.
In another group of 11 patients, whose MRI was normal, the epileptogenic lobe was less reliably identified as temporal (in two patients) or frontal (in nine) by a combination of clinical and scalp-EEG data (interictal and ictal). In the last six patients, electro-clinical and MRI data did not enable the identification of the epileptogenic lobe.
The site of seizure onset could be more precisely defined in the 40 patients who underwent an intracranial EEG study, including an SEEG investigation in 36 and recording with foramen ovale electrodes in four (Wieser and Moser, 1988 ). In addition, two patients, in whom SEEG demonstrated frontal lobe seizures, underwent a second intracranial EEG study which used subdural grids, in order to map eloquent areas and the site of seizure onset. SEEGs were performed according to the method developed by Bancaud and Talairach (Talairach et al., 1974; Munari and Bancaud, 1985; Bancaud and Chauvel, 1987; Musolino et al., 1990) , with an individually designed set of electrodes. The latter varied greatly from one patient to another, and included an average number of 11 electrodes (from 7 to 14), 87% of which were placed within the suspected epileptogenic hemisphere and 62% within the suspected epileptogenic lobes. Importantly, in the majority of temporal lobe SEEG studies the various mesial and lateral temporal structures were investigated, in addition to the temporal pole (see Fig. 1 ). Data recorded from this latter site proved critical for comparing the localizing value of FDG-PET and FMZ-PET abnormalities in temporal lobe epilepsy patients.
MRI
MRI was performed on a 1.5-T device (Magnetom 63SP; Siemens, Erlangen, Germany), and included a 3D mpr (multiplan reconstruction) T 1 -weighted acquisition [TR (repetition time) ϭ 9.7 ms; TE (echo time) ϭ 4 ms], providing 1-mm slices in all desired planes, as well as a 6-mm spin echo T 2 -weighted sequence (TR ϭ 2260 ms; TE ϭ 45 and 90 ms) parallel to the hippocampal plane and a 3-mm turbo-spin echo T 2 sequence (TR ϭ 3000 ms; TE ϭ 16 and 98 ms) perpendicular to the latter. MRI data were reviewed by two independent observers, blinded to all other data. Particular attention was payed to hippocampal abnormalities suggestive of mesial temporal sclerosis. In addition, hippocampal volumes were measured in all patients with cryptogenic temporal lobe epilepsy and no obvious MRI signs of mesial temporal sclerosis, and in those showing mild hippocampal volume asymmetry on visual analysis. These measurements were performed on 2-mm slices, perpendicular to the hippocampal plane. Depending on the individual length of the hippocampal formation, 14-17 contiguous slices were considered, from the most anterior aspect of the choroid fissure to the level of the posterior commissure. Asymmetry indices were then calculated and compared with those of 20 normal subjects, helping us to limit our analysis to the detection of unilateral hippocampal atrophy.
PET data acquisition and modelling
FMZ-PET and FDG-PET were performed on the same day, under EEG control. PET was performed in 90 patients, and in control subjects, using a time of flight device (TTV03, LETI, CENG, Grenoble, Switzerland), providing 9-mm slices with an in-plane spatial resolution of 7 mm. A personalized head holder was used for both MRI and PET scans, in order to obtain similarly oriented MRI and PET images (Cinotti et al., 1996) . Ten patients benefited from a higher performance study using a high resolution tomograph (HRϩ, Siemens, Erlangen), providing 2.4-mm slices, with an isotropic spatial resolution of 5 mm. A thermolabile plastic face mask ensured the stable position of the head in these patients. Attenuation correction was measured in each individual using a 68 Ge transmission scan. FMZ-PET was first performed, using FMZ labelled with 11 C at a specific activity varying from 300 to 500 mCi/µmol. All patients had been free of all BZD, γ-vinyl-GABA and tiagabine treatment for ജ2 weeks at the time of the PET study. We injected a bolus of 15 mCi of [ 11 C]FMZ intravenously, and subsequently acquired late [ 11 C]FMZ uptake images (20-40 min after the injection). The rationale for using this nonmodelled approach relies on the previous correlations demonstrated between late uptake and distribution volume images (r ϭ 0.996), and between these two and B max (of BZD receptors) parametric images (r ϭ 0.722) (Millet et al., 1995) . FDG-PET was performed 90 min after the last FMZ injection, using a standard procedure described elsewhere (Ryvlin et al., 1992) and the same PET device as that used for the FMZ-PET study. In order to achieve a valid comparison of patients' and control subjects' data, all images obtained with our high resolution tomograph were reformatted into sets of 9-mm slices, which were similar to those obtained with our low resolution PET device in normal subjects.
PET data analysis
First, PET images were qualitatively reviewed by two independent PET experts, blinded to other data. These investigators were asked to report all possibly significant abnormalities, including their precise anatomical locations. We then placed circular regions of interest, 10 pixels (i.e 10.1 mm) in diameter, over all PET slices displaying a visually detectable asymmetry, according to the template used in control subjects. In our experience, this region-ofinterest size best fits the actual extent of the cortical activity displayed on PET images (Ryvlin et al., 1991 (Ryvlin et al., , 1995 . Regions of interest covering the abnormal areas and the homologous contralateral regions, were further selected, and pooled into larger anatomical regions, according to the following classification: mesial temporal, temporopolar, lateral temporal, perisylvian, orbitofrontal, mesial frontal, lateral frontal, parietal and occipital. Asymmetry indices were then calculated for all identified abnormal areas as follows:
, where R and L represent the metabolic values of right and left homologous regions, respectively.
Because of the anatomical variability of PET findings in epileptic patients, we calculated specific control values for all detected abnormal areas, using the following method. We first placed circular regions of interest, 10 pixels in diameter, all over the cortical ribbon of our control PET images, using a common template and a similar number of regions of interest in every subject (n ϭ 538). We considered the patient's asymmetry index as significantly abnormal if it exceeded the mean control value Ϯ 2 SD. Only these significant PET abnormalities were taken into account in the following analysis.
Finally, significant FMZ-PET, FDG-PET and MRI abnormalities were qualitatively compared according to their respective size, location, detectability and topographical relationship with the ictal onset zone, as defined by intracranial EEG recordings, or with the suspected epileptogenic lobe(s), as suggested by non-invasive data. Table 2 ) Abnormal MRIs were found in 66 patients; these included 35 cases of mesial temporal sclerosis, 12 with mass lesions (nine low grade tumors, two cavernomas and one veinous angioma), 11 with dysgenesis (seven cortical dysplasias, two heterotopias and two hypothalamic hamartomas) and eight with miscellaneous lesions (three encephalomalacias, two focal cortical atrophies, two calcifications and one porencephalic cyst). In addition, five patients demonstrated a mild hippocampal asymmetry, which did not prove significant on quantitative analysis. The seven temporal lobe epilepsy patients with an unremarkable MRI on visual inspection also had normal hippocampal volume measurements.
Results

MRI findings (see
Qualitative versus quantitative analysis of PET data
Focal abnormalities were visually detected, by at least one investigator, on FMZ-PET and FDG-PET images in 76% and 77% of patients, respectively. In 92% of areas visually identified as abnormal, the corresponding asymmetry indices proved to be over the upper limit of normal values, using a 2-SD threshold (84% using a 3-SD threshold). Overall, FMZ-PET and FDG-PET demonstrated a significant abnormality in 73 and 75 patients, respectively. FMZ-PET sensitivity varied greatly, according to the site of seizure onset, and was significantly higher in temporal lobe epilepsy (94%) than in the other types of epilepsy (50%) (P Ͻ 0.001). There was no clear difference in the sensitivity of our two PET scanners, but the two groups studied with the two cameras were not intended to be matched. Table 2) FMZ-PET was abnormal in 44% of patients whose MRI was normal. Conversely, 12% of MRI abnormalities were associated with normal FMZ binding. All these MRI findings were either minute or subcortical.
FMZ-PET versus MRI (see
Of the patients with abnormal MRI and FMZ-PET findings, 72% presented with an abnormality of similar extent in both types of investigation, whereas the remaining 28% had a larger abnormality with FMZ-PET than with MRI. In 
ϩ ϭ abnormal; -ϭ normal; n.p. ϭ not pertinent. *Including five patients with a non-significant hippocampal atrophy.
particular, mesial temporal sclerosis was associated with a decreased FMZ binding involving the mesial temporal structures and the temporal pole or the lateral temporal cortex in 10 patients (Fig. 1) . Table 2) FMZ-PET was abnormal in four patients whose FDG-PET did not show any significant asymmetry, whereas it was normal in six patients with focal hypometabolism. In four other patients, the two investigations showed strikingly different abnormalities, including opposite lateralizations in three (see next paragraph). Sixty-five patients demonstrated a concordant FMZ-PET and FDG-PET asymmetry, the latter being larger than the former in 48% of cases ( Fig. 2) and of similar size in the other 52% (Fig. 1) .
FMZ-PET versus FDG-PET (see
FMZ-PET versus electro-clinical data
FMZ-PET provided false lateralization in three temporal lobe epilepsy patients whose FDG-PET was correctly lateralizing, and a false lobar localization in four other patients who suffered from parietal or frontal lobe epilepsy. These four latter patients each demonstrated a temporal decreased FMZ binding associated with an underlying MRI finding of uncertain significance (a non-significant hippocampal volume asymmetry in two patients and temporopolar calcifications in the other two). Overall, 66 patients showed a decreased FMZ binding in their epileptogenic lobe(s), including eight whose MRI was either normal (n ϭ 6) or showed a non-significant hippocampal volume asymmetry (n ϭ 2) and three whose FDG-PET was unremarkable. The precise topographical relationships between the site of FMZ-PET abnormalities and the ictal onset zone, and the potential clinical utility of FMZ-PET, will be presented below and in Table 3 . The different types of epilepsy will be considered successively.
FMZ-PET in unilateral temporal lobe epilepsy associated with MRI signs of mesial temporal sclerosis
In this homogeneous group of 30 patients, FMZ-PET always demonstrated a decreased FMZ binding over the sclerotic mesial temporal structures, which extended towards the temporal pole or the lateral temporal cortex in seven cases (Fig. 1) . FDG-PET, which was abnormal in 29 of these 30 patients, demonstrated a larger abnormality than FMZ-PET in 19 patients (Fig. 2) , and a similar one in the other 10 (Fig.  1) . Importantly, all patients with coextensive FMZ-PET and FDG-PET abnormalities who underwent an SEEG investigation (n ϭ 10) had a temporolimbic epileptogenic zone that matched the area of PET abnormalities well (see Table 4 ). Conversely, patients whose extent of hypometabolism was larger than that of decreased FMZ binding, demonstrated an epileptogenic zone which matched the FMZ-PET abnormality (n ϭ 2), or the FDG-PET abnormality (n ϭ 4), or was intermediate between the two (n ϭ 5).
Overall, PET findings were useful in patients with unilateral temporal lobe epilepsy and MRI signs of mesial temporal sclerosis, since they provided evidence of a more widespread pathology than that suggested by MRI. However, the extent of the ictal onset zone was often underestimated by FMZ-PET and overestimated by FDG-PET. The combination of both investigations allowed the identification of a subgroup of patients with coextensive hypometabolism and decreased FMZ binding, the extent of which closely matched that of the ictal onset zone. This latter population represented onethird of temporal lobe epilepsy patients with mesial temporal sclerosis. 
FMZ-PET in unilateral temporal lobe epilepsy associated with a normal MRI
FMZ-PET was abnormal in six of these seven patients, including two whose FDG-PET was unremarkable (Fig. 3) . Importantly, the FMZ-PET abnormality was falsely lateralized in two patients, disclosing decreased mesial temporal FMZ binding in a region contralateral to that of seizure onset and hypometabolism. Among the four other patients with an abnormal FMZ-PET, three underwent an SEEG which showed that the ictal onset zone encompassed, and was larger than, the area of decreased FMZ binding (see Table 4 ). One of these three patients demonstrated a larger area of hypometabolism which was more closely correlated with the epileptogenic zone. Overall, FMZ-PET was more sensitive but less reliable than FDG-PET in patients with unilateral temporal lobe epilepsy and a normal MRI.
FMZ-PET in unilateral temporal lobe epilepsy associated with a mass lesion
Eight of these nine patients demonstrated a FMZ-PET abnormality that matched the MRI lesion. The remaining patient presented with a small right mesial temporal cavernoma, which proved responsible for his epileptic condition, and a falsely lateralized left mesial temporal FMZ-PET abnormality. Overall, FMZ-PET did not prove clinically useful in this group of patients.
FMZ-PET in bi-temporal epilepsy
Interestingly, two of these six patients showed bilateral FMZ-PET abnormalities, affecting different aspects of the right and left temporolimbic structures (Fig. 4) . The four other patients demonstrated a symmetrical FMZ binding (n ϭ 2) or a unilateral abnormality (n ϭ 2). Overall, FMZ-PET was useful in this small group of patients, by supporting the bitemporal origin of seizures in 33% of cases.
FMZ-PET in unilateral frontal lobe epilepsy associated with a MRI lesion
This group of eight patients showed a variety of MRI lesions, including three cortical dysplasias, two encephalomalacias, one oligodendroglioma, one venous angioma and one porencephalic cyst. In five patients, FMZ-PET and FDG-PET demonstrated a similar abnormality that grossly matched the MRI lesion and clearly underestimated the epileptogenic zone in the two patients who underwent an SEEG (see Table 5 ). FMZ-PET and FDG-PET were normal in two other patients whose MRI lesion was either minute or subcortical. In the remaining patient, who had a small frontal cortical dysplasia, the two PET investigations showed multilobar abnormalities (frontal, temporal and parietal), whereas a simple lesionectomy resulted in the complete cessation of seizures during the 2 years of post-surgical follow-up. Overall, neither FMZ-PET nor FDG-PET proved useful in this group of patients.
FMZ-PET in cryptogenic unilateral frontal lobe epilepsy
A decreased FMZ binding was observed in six of these 11 patients (55%), pointing to the epileptogenic frontal lobe in half of them and to the ipsilateral temporal lobe in the other half. These latter abnormalities were colocalized with MRI MTS  MT  MT  MT  MTS  MT  MT  MT  MTS  MT  MT  MT  MTS  MT-TP  MT-TP  MT-TP  MTS  MT-TP  MT-TP  MT-TP NS HA ϭ non-significant hippocampal asymmetry; TP ϭ temporal pole; MT ϭ mesial temporal; LT ϭ lateral temporal; MO ϭ mesial occipital. *Falsely localizing abnormalities.
findings of uncertain significance, including temporal microcalcifications in two patients and a mild hippocampal volume asymmetry in another one. Among the three patients with a frontal FMZ-PET abnormality, two underwent an SEEG investigation. According to this, the area of decreased FMZ binding was part of a large epileptogenic network, but it did not corrrespond to the most epileptogenic region (see Table 5 and Fig. 5 ). In comparison, FDG-PET was abnormal in five patients, and was only associated with the epileptogenic frontal lobe in one patient. Overall, FMZ-PET was more informative than FDG-PET in cryptogenic unilateral frontal lobe epilepsy, although it did not precisely identify the ictal onset zone.
FMZ-PET in cryptogenic frontal lobe epilepsy associated with bilateral spike and wave discharges
No FMZ-PET or FDG-PET abnormality was observed in this group of eight patients.
FMZ-PET in the remaining patients
This heterogeneous group of 21 patients included 13 with multilobar epilepsies (five temporofrontal, four temporoinsulo-opercular and four temporo-occipital), nine of whom had an abnormal MRI. Eight of these 13 patients (62%) showed a FMZ-PET abnormality, which always matched that observed on FDG-PET images. SEEG data correlated well with PET findings in only two of these patients (see Table 5 ). In four others, the FMZ-PET abnormality was located within the ictal onset zone, but largely underestimated its size. This was particularly true in two patients with a typical temporolimbic FMZ-PET pattern and a temporofrontal epilepsy. Overall, FMZ-PET did not provide more pertinent data than those obtained with FDG-PET in this population. The same conclusion applied to the eight patients whose seizure origin was either parietal, occipital or undetermined.
Discussion
We have reported a large prospective FMZ-PET study with 100 patients being evaluated for drug-resistant partial epilepsy. The clinical utility of this PET investigation was compared with that of previously validated neuro-imaging methods, including MRI and FDG-PET, with respect to detailed electro-clinical data. Our overall conclusion is that FMZ-PET cannot be considered superior to FDG-PET, but might provide useful complementary data in specific categories of patients. Before discussing these issues in detail, we need to address some methodological aspects of our work.
Methodological issues
For the purpose of this clinical study, we have used a simplified FMZ-PET approach which could be achieved realistically at the present time by the majority of groups using PET as a clinical tool in epilepsy surgery. In particular, we have used late FMZ uptake images, as previously proposed by other groups (Savic et al., 1993; Debets et al., 1997) . Late FMZ uptake data are known to be closely correlated with distribution volume images (Millet et al., 1995) , which have been used in the majority of previously reported series (Henry et al., 1993; Koepp et al., 1996 Koepp et al., , 1997 Richardson et al., 1996; Szelies et al., 1996) . Moreover, both late uptake and distribution volume images correlate with B max parametric images, and can thus be considered as valid indices of BZD receptor density (Savic et al., 1993; Millet et al., 1995) . Finally, only a single patient has been reported as demonstrating decreased BZD receptor density on B max parametric images, which was not detectable on late uptake images (Savic et al., 1993) , suggesting a similar sensitivity of both methods.
We have used a time-efficient semi-quantitative analysis of FMZ-PET data, which did not require the coregistration of MRI and PET images. Based on normative data obtained from a template of 538 contiguous circular regions of interest which sampled the entire cortical ribbon, we could test the significance of any visually detected asymmetry in our patients rapidly, by placing circular regions of interest over the abnormal zone. We could match the slice level, and the position of the asymmetric area, with the corresponding region in the regions-of-interest template reliably, since all our PET images were scanned using a precisely defined hippocampal orientation (Cinotti et al., 1996) .
However, this method has some limitations, the clinical impact of which must be discussed. (i) The detection of PET abnormalities primarily relied on visual analysis, which has been suggested to be less sensitive than quantitative analysis (Swartz et al., 1995) . We have dealt with this issue by asking the investigators to favour sensitivity against specificity, inasmuch as false positive findings would ultimately be rejected by our semi-quantitative analysis. In fact, 8% of the visually detected FMZ-PET asymmetries were not statistically significant. Most of these false positive findings corresponded to asymmetry indices between 6% and 10%. Overall, visual analysis proved highly sensitive and unlikely to miss significant FMZ-PET asymmetries. (ii) We could not detect bilateral symmetrical changes in this study. However, such findings do not help in deciding on the most appropriate surgical strategy. For instance, temporal lobe epilepsy patients presenting with bilateral symmetrical hippocampal atrophy on MRI were reported to have a postoperative seizure outcome similar to that in temporal lobe epilepsy patients whose MRI was strictly normal (Arruda et al., 1996) . Therefore, we did not consider the detection of bilateral symmetrical FMZ-PET abnormalities as clinically relevant in the context of this study. (iii) We did not correct our PET data for a partial volume effect. This type of procedure recently proved critical in understanding the pathophysiology of mesial temporal decreased FMZ binding (Koepp et al., 1997) . However, its utility in the clinical applications of FMZ-PET remains to be determined. Indeed, in temporal lobe epilepsy patients with MRI signs of mesial temporal sclerosis, the demonstration that at least some of the hippocampal FMZ-PET abnormalities are not related to a partial volume effect is unlikely to modify the surgical decision regarding the resection of mesial temporal structures. On the other hand, in patients without MRI evidence of mesial temporal sclerosis (including normal hippocampal volumetry), the detection of a significant mesial temporal abnormality on FMZ-PET images seems very unlikely to be due to a partial volume effect, provided that the possibility of tilted images has been excluded. (iv) Significant asymmetries on FMZ-PET images can either correspond to a decreased FMZ binding on one side or an increased binding on the other side. In most instances, our qualitative analysis of PET images could easily distinguish between these two possibilities, based on the overall pattern of cortical activity and the gradient usually observed between normal and abnormal areas within the epileptogenic hemisphere. However, in the rare patients with falsely lateralized FMZ-PET abnormalities, additional quantitative analysis would need to be performed to assess the origin of the observed asymmetries positively. In this respect, SPM (statistical parametric mapping) appears to be an efficient method for the detection of increased FMZ binding and bilateral symmetrical changes . However, this method could not be applied to our data reliably, since our PET slices were relatively thick (9 mm) and precluded adequate matching between individual patients' images and a SPM database.
FMZ-PET sensitivity
The 73% sensitivity of FMZ-PET in this series was less than in all previous reports (see Table 1 ). This probably results from the large variety of partial epilepsies included in our study. Indeed, most patients who failed to demonstrate a significant FMZ-PET abnormality suffered from a cryptogenic partial epilepsy, the origin of which was either unknown, bi-frontal or multilobar. Conversely, FMZ-PET sensitivity was 100% in temporal lobe epilepsy patients with MRI signs of mesial temporal sclerosis and 94% among all temporal lobe epilepsy patients, a figure very similar to that of other comparable series (Savic et al., 1988 (Savic et al., , 1993 Henry et al., 1993; Koepp et al., 1996 Koepp et al., , 1997 Szelies et al., 1996; Debets et al., 1997) .
FMZ-PET versus MRI
FMZ-PET was slightly more sensitive than MRI in our population (73% versus 66%). A few subcortical or minute MRI findings were not associated with decreased FMZ binding, and 44% of our patients with a strictly normal MRI demonstrated a significant FMZ-PET abnormality. These results cannot readily be compared with those obtained from most other series, which either involved populations with a very high incidence of MRI abnormalities, from 96% to 100% (Koepp et al., , 1997 Richardson et al., 1996; Debets et al., 1997) , or temporal lobe epilepsy patients in whom MRI signs of mesial temporal sclerosis were not specifically evaluated (Savic et al., 1988 (Savic et al., , 1993 (Savic et al., , 1996 Henry et al., 1993) .
FMZ-PET abnormalities had a larger spread than MRI changes in 28% of cases. This was observed mostly in patients with MRI signs of hippocampal sclerosis, where the decreased FMZ binding could affect temporopolar, lateral temporal and extra-temporal structures. Similar FMZ-PET abnormalities in temporal lobe epilepsy patients have occasionally been reported (Henry et al., 1993; Savic et al., 1993 Savic et al., , 1996 . Conversely, Koepp et al. (1996) did not find BZD receptor changes outside the mesial temporal structures in their series of 12 patients with temporal lobe epilepsy and MRI signs of mesial temporal sclerosis. These differences might be due to the various methods used in the analysis of PET images or to the small number of patients included in previous series. Dysgenesic lesions have also been found to be associated with larger abnormalities in FMZ-PET than in MRI , as observed in three of our patients. The decreased FMZ binding observed outside the visually detectable lesion might, alternatively, indicate a more extensive neuronal loss than that suggested by MRI or functional changes of BZD receptors Savic et al., 1996; Koepp et al., 1997) .
FMZ-PET versus FDG-PET
FMZ-PET was slightly more sensitive than FDG-PET in patients with temporal or frontal lobe epilepsy, in accordance with the results of most previous studies (Henry et al., 1993; Savic et al., 1993 Savic et al., , 1995 Szelies et al., 1996) . The rare FMZ-PET abnormalities which were not detected on FDG-PET typically affected the mesial temporal structures. As previously reported, we found that metabolic abnormalities were often more widespread than the corresponding areas of decreased FMZ binding in temporal lobe epilepsy patients (62%), but this was only rarely the case in extra-temporal epilepsies (10%). This might be due to the likelihood of observing a corticocortical diaschisis in temporal lobe epilepsy, but not in other forms of partial epilepsy (Ryvlin et al., 1991 (Ryvlin et al., , 1995 .
FMZ-PET versus electro-clinical data
Studies in which FMZ-PET and FDG-PET have been compared have suggested that BZD receptor changes correlate more closely with the epileptogenic zone than do glucose metabolism abnormalities (Henry et al., 1993; Savic et al., 1993; Szelies et al., 1996) . This statement mainly applies to the PET findings observed in cryptogenic temporal lobe epilepsy (see above), provided that the associated epileptogenic zone remains limited to the mesial temporal structures. However, the temporopolar and lateral aspects of the temporal lobe can also be involved at seizure onset in cryptogenic temporal lobe epilepsy (Ryvlin et al., 1997) . Based on similar findings, Debets et al. (1997) recently concluded that FMZ-PET did not prove superior to FDG-PET in localizing the origin of temporal lobe seizures. Our own data are consistent with this conclusion and even suggest that, in some patients, abnormalities of glucose metabolism match the epileptogenic zone better than BZD receptor changes. For example, patients who demonstrated a decreased FMZ binding which was restricted to the hippocampal formation, and a hypometabolic zone covering the mesial temporal and temporopolar structures, often presented with seizures originating concomitantly in the amygdalohippocampal complex and the temporal pole. Moreover, FMZ-PET abnormalities were falsely lateralized in three of our patients, whereas FDG-PET always indicated the epileptogenic hemisphere. The falsely lateralized FMZ-PET asymmetries were found to fluctuate over time , and seem likely to represent functional changes of BZD receptors. These changes might correspond to a transient downregulation in the mesial temporal structures contralateral to seizure onset, which represent a major site of propagation of temporolimbic seizures. Similarly, in patients with frequent seizures, Savic et al. (1996) have observed decreased B max values in projection areas from the epileptogenic zone, which normalized after epilepsy surgery (Savic et al., 1998) . Alternatively, the transient and falsely lateralized FMZ-PET asymmetries observed in our patients might result from an upregulation of BZD receptors ipsilateral to seizure onset. Interestingly, a transient upregulation of BZD receptors was consistently detected in the hippocampal formation of kindled animals, 24 h after the kindling procedure was completed (McNamara et al., 1980; Valdez et al., 1982; Shin et al., 1985; Nobrega et al., 1989; Ben Attia et al., 1992) . Our semi-quantitative data do not enable us to choose between the two above hypotheses.
Clinical utility of FMZ-PET
This issue raised the question of the gold standard considered in the comparative evaluation of MRI and PET data. Whenever possible, we have favoured the use of the SEEG ictal onset over that of the post-surgical outcome, for the following reasons. (i) We wished to identify clinical situations where FMZ-PET data can help in anticipating the SEEG conclusions and, eventually, eliminating invasive EEG monitoring. (ii) From a theoretical point of view, the lack of seizure relapse following surgery indicates that the epileptogenic zone was included in the resected area, but not that the two were actually coextensive in space. (iii) Several factors, other than the identification of the ictal onset zone, influence the post-surgical outcome. For instance, a clearly insufficient cortical resection was apparent on the postoperative MRI of our two temporal lobe epilepsy patients who experienced recurrent seizures after surgery. (iv) SEEG offers the possibility of exploring brain regions which are often shown to be differentially affected on MRI, FDG-PET and FMZ-PET, particularly the temporal pole. This latter structure proved to be frequently involved at seizure onset, together with mesial temporal structures (Ryvlin et al., 1997) , and it was therefore critical to investigate this structure in order to compare the value of the various neuro-imaging techniques in localizing the lesion adequately.
The clinical utility of FMZ-PET needs to be addressed separately for the different types of epilepsies considered in this paper.
In typical temporal lobe epilepsy associated with MRI signs of mesial temporal sclerosis, FMZ-PET findings often appear redundant Debets et al., 1997) . However, in some patients, PET discloses an area of decreased FMZ binding larger than the MRI abnormality, which typically involves the temporal pole and, more rarely, the lateral temporal cortex. Whether or not this information is relevant for epilepsy surgery remains uncertain. Indeed, we could not demonstrate a tight congruence between the area of BZD receptor changes and the epileptogenic zone, unlike Savic et al. (1988 Savic et al. ( , 1993 . In our population of temporal lobe epilepsy patients with MRI signs of mesial temporal sclerosis, the extent of the ictal onset zone was always found intermediate between those of the FMZ-PET and FDG-PET abnormalities. Accordingly, when FMZ-PET and FDG-PET abnormalities were strictly coextensive, they also closely matched the area of seizure onset, as established with SEEG recordings. In this situation, the combination of both PET investigations seems to provide sufficient data to decide between an anterior temporal lobectomy and an amygdalohippocampectomy, without performing intracranial EEG recordings. This conclusion should be validated by a specifically designed prospective study.
In the temporal lobe epilepsy patients whose MRI was normal, FMZ-PET provided various results, depending on FDG-PET data. When the latter were also normal, FMZ-PET was informative, showing a decreased FMZ binding within the epileptogenic temporal lobe in two-thirds of cases. Conversely, in patients presenting with temporal hypometabolism on FDG-PET, FMZ-PET often demonstrated a falsely lateralized asymmetry. Therefore, FDG-PET should be considered as the first line PET investigation in temporal lobe epilepsy patients with a strictly normal MRI, and FMZ-PET could be proposed in the subgroup of patients whose FDG-PET failed to reveal focal hypometabolism.
In our experience, one-third of patients whose intracranial EEG demonstrated a bi-temporal epilepsy also had bilateral temporal decreased FMZ binding. This pattern was specifically encountered in this population, and could help to predict the bilateral origin of temporal lobe seizures.
FMZ-PET was moderately informative in patients with unilateral cryptogenic frontal lobe epilepsy, showing an abnormality in 55% (compared with 45% for FDG-PET). Although these abnormalities always pointed to the epileptogenic hemisphere, they correctly indicated the epileptogenic lobe in only 50% of cases, and never indicated the ictal onset zone precisely. These results clearly contrast with those reported in six patients by Savic et al. (1995) , where the decreased FMZ binding closely matched the site of seizure onset. Nevertheless, the correct identification of the epileptogenic hemisphere in all patients displaying an abnormal FMZ-PET could help in the design of the intracranial EEG investigation.
Patients with cryptogenic frontal lobe epilepsy associated with bilateral scalp-EEG discharges represent one of the most difficult challenge for epilepsy surgery. Unfortunately, FMZ-PET did not prove informative in this population.
In patients with multilobar epilepsy, a clearly epileptogenic MRI lesion (excluding mesial temporal sclerosis) or a nonlocalized epileptogenic zone, FMZ-PET failed to provide any pertinent information, other than that obtained with FDG-PET. Indeed, both PET investigations demonstrated similar abnormalities in most of these patients.
Conclusion
FMZ-PET appears to provide clinically useful data, complementary to those offered by MRI and FDG-PET, in the pre-surgical evaluation of specific subgroups of epileptic patients. (i) In temporal lobe epilepsy patients with MRI signs of mesial temporal sclerosis, the combination of FDG-PET and FMZ-PET data can help in the precise mapping of the ictal onset zone and, thus, in deciding the most appropriate surgical procedure, provided that all neuro-imaging findings are consistent with scalp-EEG data.
(ii) In patients with suspected bi-temporal epilepsy, FMZ-PET can confirm the bilaterality of the epileptic disorder. (iii) In patients with a unilateral cryptogenic frontal lobe epilepsy, FMZ-PET can provide further evidence of the side and site of seizure onset. The possibility that more sophisticated data analysis, such as an objective quantitative approach based on SPM, might demonstrate additional clinical utility of FMZ-PET deserves future study.
